Dengue Treatment Market by Drug Class (NSAIDS, Antibiotics, Corticosteroids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Geography

Dengue Treatment Market size was valued at USD 324.3 million in 2022 and is growing at a CAGR of 13.6% from 2023 to 2029. The global market provides a detailed overview and that can be segmented by drug class and by distribution channel. By drug class, the global dengue treatment market has been segmented into NSAIDS, Antibiotics, and Corticosteroids. The NSAIDs dengue treatment segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the forecasted years. Based on the distribution channel, the segment has been segregated into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. The Hospital pharmacies segment is expected to dominate other segments in the global dengue treatment market. The retail pharmacies segment is expected to witness the highest CAGR during the forecast period according to precision business insights. Dengue fever is also known as break bone fever is mosquito born and endemic disease that leads to severe flu like illness. Dengue caused by RNA virus dengue belongs to the family Flaviviridae. Dengue is spread by several species of mosquitos of the Aedes type, principally A. aegypti. Symptoms of dengue include fever, headache vomiting, muscle and joint pains, and characteristic skin rash. On infection of dengue, patient will automatically recover within seven days. But in some cases, it may develop to life threatening dengue haemorrhagic fever. The virus has five different types of strains, infection with one strain usually gives lifelong immunity to that type. Subsequent infection with a different type of dengue virus increases the risk of severe complications.